FDA cooperative agreements for adverse drug effect studies
Executive Summary
Center for Drug Evaluation and Research anticipates the availability of $1.7 mil. in FY 1994 funds for cooperative agreements to study serious and infrequent adverse effects of marketed drugs, according to Aug. 11 Federal Register. Applications are available from Stephanie Seligman, Grants and Assistance Agreements Section, (HFA-522), FDA, Park Building, Rm. 3-40, 5600 Fishers Lane, Rockville, Md. 20857.